25年间死后神经退行性与脑血管神经病理学的趋势
该研究分析了宗教修会研究和拉什记忆与老龄化项目两个纵向队列1997至2022年的尸检数据,纳入1554名参与者,按出生年份分为四个出生队列,比较死后神经病理学的年龄标准化患病率。结果显示病理性AD诊断的患病率在各出生队列间无差异(62%至68%,P=.76),但晚出生队列的tau缠结密度更高(P=.01),而动脉粥样硬化和动脉硬化显著降低(中重度动脉粥样硬化从54%降至22%,P<.001)。作者认为临床痴呆的改善可能与对病理的韧性提高有关,而非AD病理减少。
要点
- 病理性AD诊断的年龄标准化患病率在各出生队列间无差异,波动于62%至68%(P=.76)。
- 晚出生队列的tau缠结密度更高,例如1905-1914队列年龄标准化均值1.53年,1925-1930队列1.87年(P=.01)。
- 中重度动脉粥样硬化的年龄标准化患病率从1905-1914队列的54%降至1925-1930队列的22%(P<.001)。
核心结论
- 神经退行性病理差异很少,但25年间出生队列的tau缠结水平可能更差;临床痴呆的改善可能部分与对病理的韧性提高有关,而非AD病理减少;血管病理显著降低,提示人群血管危险因素的改善与脑健康相关。
研究设计与样本
- 分析宗教修会研究和拉什记忆与老龄化项目两个纵向队列1997至2022年的尸检数据,随访长达27年,纳入1554名有完整死后神经病理评估的死者,排除出生年份最远(<1905)或最近(>1930)的177人。
主要发现
- 病理性AD诊断的年龄标准化患病率在各出生队列间无差异,波动于62%至68%(χ2检验:P=.76)。
- 全球AD病理的平均水平无差异,但晚出生队列的tau缠结密度更高,例如1905-1914队列年龄标准化均值(SD)为1.53(1.20)年,1925-1930队列为1.87(1.47)年(方差分析:P=.01)。
- 其他神经退行性病理随时间无差异。
- 中重度动脉粥样硬化的年龄标准化患病率从1905-1914队列的54%降至1925-1930队列的22%(χ2检验:P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: With rapid aging of the US population, understanding trends over time in dementia occurrence is essential to public health planning and intervention; this understanding includes trends in neuropathologies underlying clinical dementia. OBJECTIVE: To characterize trends in pathways underlying dementia by examining prevalence of postmortem neuropathologies in birth cohorts across 25 years. DESIGN, SETTING, AND PARTICIPANTS: Two longitudinal cohorts, the Religious Orders Study and the Rush Memory and Aging Project, with autopsy data from 1997 to 2022 with up to 27 years follow-up were analyzed. Deceased individuals with complete postmortem neuropathology evaluations were included, and 177 individuals with most distant (<1905) or recent (>1930) years of birth were excluded. EXPOSURES: Four categories of year of birth: 1905-1914, 1915-1919, 1920-1924, and 1925-1930. MAIN OUTCOMES AND MEASURES: Outcomes included pathologic diagnosis of Alzheimer disease (AD), global AD pathology, amyloid load, tau tangles, neocortical Lewy bodies, limbic-predominant age-related TDP-43 encephalopathy neuropathological change, atherosclerosis, arteriolosclerosis, gross chronic infarcts, and chronic microinfarcts. For comparison, pathologies in each birth epoch were age-standardized to age distribution of the cohorts. χ2 Tests were used for categorical outcomes, and analysis of variance was used to compare means across birth epochs. RESULTS: Overall, 1554 participants were examined (510 [33%] male; median [range] age at death, 90 [66-108] years). Participants were distributed fairly evenly across birth epochs (1905-1914: n = 374; 1915-1919: n = 360; 1920-1924: n = 466; 1925-1930: n = 354). Across year of birth groups, no differences were found in prevalence of pathologic AD diagnosis; age-standardized prevalence fluctuated between 62% and 68% in the birth cohorts (χ2 test: P = .76 across birth epochs). Similarly, no differences were found in mean levels of global AD pathology, although there was greater density specifically of tau tangles in later birth cohorts (eg, age-standardized mean [SD], 1.53 [1.20] years for the 1905-1914 cohort and 1.87 [1.47] years for the 1925-1930 cohort; analysis of variance test: P = .01 across birth cohorts). There were no differences over time in other neurodegenerative pathologies. In contrast, atherosclerosis and arteriosclerosis were dramatically lower over time; for example, age-standardized prevalence of moderate to severe atherosclerosis ranged from 54% among those born from 1905-1914 to 22% for 1925-1930 (χ2 test: P < .001 across birth epochs). CONCLUSION AND RELEVANCE: In this study, few differences in neurodegenerative pathologies were found, but there may be worse levels of tau tangles across birth cohorts over 25 years. This indicates that any improvements over time in clinical dementia observed by cohorts are likely in part associated with improved resilience to pathology rather than reduced AD pathology. Finally, vessel pathologies were markedly lower over birth cohorts, indicating the assocation with brain health of populationwide improvements in several vascular risk factors.
引用
- Grodstein F, Leurgans SE, Capuano AW, et al. Trends in Postmortem Neurodegenerative and Cerebrovascular Neuropathologies Over 25 Years. JAMA Neurol. 2023. PMID: 36805154. doi:10.1001/jamaneurol.2022.5416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。